Bifonazole

联苯苄唑

Report date: 2023/03/16 15:08:24
NME

Base Information

Drug NameBifonazole
Drug Alias Name联苯苄咪唑bifonazolebifonazolumbifonazolCanespor +[10
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsTinea PedisOnychomycosisDermatomycoses
Global Approved IndicationsDermatomycoses
Approved Indications in ChinaDermatomycoses
Original Approved Country/TerritoryJapan
Original Approved Date1986/11/28
Country/TerritoryCzechiaPolandGermany +[6
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Inactive CompaniesBayer AG
Active IndicationsDermatomycoses
Inactive IndicationsTinea PedisOnychomycosis

Other Information

ATC CodeD01AC10